T 2165/08 (Bi-cyclic nucleoside analogues/EXIQON) of 6.3.2013

European Case Law Identifier: ECLI:EP:BA:2013:T216508.20130306
Date of decision: 06 March 2013
Case number: T 2165/08
Application number: 98942516.0
IPC class: C07H 21/00
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 232 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished | Unpublished v2
Title of application: Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
Applicant name: Exiqon A/S
Opponent name: Isis Pharmaceuticals, Inc.
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 87
European Patent Convention Art 104(1)
European Patent Convention Art 123(2)
Rules of procedure of the Boards of Appeal Art 12(2)
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(3)
Rules of procedure of the Boards of Appeal Art 16(1)
Keywords: Main request - inventive step (no)
Auxiliary request 1 and 2 - not admitted
Auxiliary request 3 - added matter (no), novelty (yes), inventive step (yes)
Catchwords:

-

Cited decisions:
G 0001/93
G 0002/98
G 0001/03
G 0002/10
T 0201/83
T 1067/97
T 0714/00
T 1329/04
T 1834/09
Citing decisions:
T 1880/09
T 0702/15
T 0403/17

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t082165eu1.html

Date retrieved: 17 May 2021

18 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: III Amendments

Case Law of the Enlarged Board

General Case Law